Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans

Drug Metabolism and Disposition

Volumn 25, Issue 6, 1997, Pages 716-724

  Kashiyama, Eiji ^b   Yokoi, Tsuyoshi ^b   Odomi, Masaaki ^b   Funae, Yoshihiko ^b   Inoue, Kazuaki ^b   Kamataki, Tetsuya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ALCOHOL; ANTISERUM; CLOFIBRATE; CYTOCHROME P450; DEXAMETHASONE; FLOSEQUINAN; OXIDOREDUCTASE; PHENOBARBITAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG OXIDATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; STEREOCHEMISTRY;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; MALE; MICROSOMES, LIVER; OXIDATION-REDUCTION; OXIDOREDUCTASES, N-DEMETHYLATING; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0030996333     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. A. J. Cowley, R. D. Wynne, and J. R. Hampton: The effects of BTS 49 465 on blood pressure and peripheral arteriolar and venous tone in normal volunteers. J. Hypertens. 2 (Suppl. 3), 547-549 (1984).
2. D. B. Yates: Pharmacology of flosequinan. Am. Heart J. 121, 974-983 (1991).
3. E. Kashiyama, T. Todaka, M. Odomi, Y. Tanokura, D. B. Johnson, T. Yokoi, T. Kamataki, and T. Shimizu: Stereoselective pharmacokinetics and chiral interconversions of flosequinan enantiomers containing chiral sulphoxide in rat. Xenobiotica 24, 369-377 (1994).
4. A. P. Kulkarni and E. Hodgson: Metabolism of insecticides by mixed function oxidase system. Pharmacol. Ther. 8, 379-475 (1980).
5. D. M. Ziegler: Microsomal flavin-containing monooxygenase: oxygenation of nucleophilic nitrogen and sulfur compound. In "Enzymatic Basis of Detoxication" (W. B. Jacoby, ed.), pp. 201-227. Academic Press, New York, 1980.
6. D. M. Ziegler: Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annu. Rev. Pharmacol. Toxicol. 33, 179-199 (1993).
7. D. R. Nelson, L. Koymans, T. Kamataki, J. J. Stegeman, R. Feyereisen, D. J. Waxman, M. R. Waterman, O. Gotoh, M. J. Coon, R. W. Estabrook, I. C. Gunsalus, and D. W. Nebert: The P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42 (1996).
8. M. P. Lawton, and R. M. Philpot: Molecular genetics of the flavin-dependent monooxygenase. Pharmacogenetics 3, 40-44 (1993).
9. E. Kashiyama, T. Yokoi, K. Itoh, S. Itoh, M. Odomi, and T. Kamataki: Stereoselective S-oxidation of flosequinan sulfide by rat hepatic flavin-containing monooxygenase 1A1 expressed in yeast. Biochem. Pharmacol. 47, 1357-1363 (1994).
10. T. Kamataki, and H. Kitagawa: Effects of lipid peroxidation on activities of drug-metabolizing enzymes in liver microsomes of rats. Biochem. Pharmacol. 22, 3199-3207 (1973).
11. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
12. E. Kashiyama, M. Odomi, and T. Shimizu: Stereospecific and simultaneous high-performance liquid chromatographic assay of flosequinan and its metabolites in human plasma. J. Chromatogr. 652, 179-185 (1994).
13. E. Kashiyama, T. Yokoi, T. Todaka, M. Odomi, and T. Kamataki: Chiral inversion of drug: role of intestinal bacteria in the stereoselective sulfoxide reduction of flosequinan. Biochem. Pharmacol. 48, 237-243 (1994).
14. M. Isogai, N. Shimada, T. Kamataki, S. Imaoka, and Y. Funae: Change in the amounts of cytochrome P450 in rat hepatic microsomes produced by cyclosporin A. Xenobiotica 23, 799-807 (1993).
15. C. F. Neville, S. Ninomiya, N. Shimada, T. Kamataki, S. Imaoka, and Y. Funae: Characterization of specific cytochrome P450 enzymes responsible for the metabolism of diazepam in hepatic microsomes of adult male rats. Biochem. Pharmacol. 45, 59-65 (1993).
16. U. K. Laemmli: Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685 (1970).
17. F. P. Guengerich, P. Wang, and N. K. Davidson: Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry 21, 1698-1706 (1982).
18. D. E. Ryan, and W. Levin: Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol. Ther. 45, 153-239 (1990).
19. F. Kamali, and C. Edwards: Conversion of flosequinan to the sulphone metabolite in subcellular fractions of human liver, in-vitro. J. Pharm. Pharmacol. 45, 581-584 (1993).
20. R. D. Wynne, E. L. Crampton, and I. D. Hind: The pharmacokinetics and haenodynamics of BTS 49 465 and its major metabolite in healthy volunteers. Eur. J. Clin. Pharmacol. 28, 659-664 (1986).
21. M. W. Anders, J. H. Ratnayake, P. E. Hanna, and J. A. Fuchs: Involvement of thioredoxin in sulfoxide reduction by mammalian tissues. Biochem. Biophys. Res. Commun. 97, 846-851 (1980).
22. S. Yoshihara, and K. Tatsumi: Guinea pig liver aldehyde oxidase as a sulfoxide reductase: its purification and characterization. Arch. Biochem. Biophys. 242, 213-224 (1985).
23. A. G. Renwick, H. A. Strong, and C. F. George: The role of the gut flora in the reaction of sulphoxide containing drugs. Biochem. Pharmacol. 31, 2649-2656 (1982).
24. V. Kobliakv, N. Popova, and L. Possi: Regulation of the expression of the sex-specific isoforms of cytochrome P-450 in rat liver. Eur. J. Biochem. 195, 585-591 (1991).
25. A. R. Boobis, D. W. Nebert, and J. S. Felton: Comparison of β-naphthoflavone and 3-methylcholanthrene as inducers of hepatic cytochrome(s) P-448 and aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity. Mol. Pharmacol. 13, 259-268 (1997).
26. D. E. Ryan, D. R. Koop, P. E. Thomas, M. J. Coon, and W. Levin: Evidence that isoniazid and ethanol induce the same microsomal cytochrome P-450 in rat liver, an isozyme homologous to rabbit liver cytochrome P-450 isoxyme 3a. Arch. Biochem. Biophys. 246, 633-644 (1986).
27. A. Wrighton, E. G. Schuetz, P. B. Watkins, P. Maurel, J. Barwick, B. S. Bailey, H. Hartle, B. Young, and P. S. Guzelian: Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNA related to the glucocorticoid-inducible cytochrome P-450 of the rat. Mol. Pharmacol. 28, 312-321 (1985).
28. D. J. Waxman, G. A. Dannan, and F. P. Guengerich: Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and inducibility of sex-specific isozymes. Biochemistry 24, 4409-4417 (1985).
29. L. Clarke, and D. J. Waxman: Oxidative metabolism of cyclophosphamide. Identification of the hepatic monooxygenase catalysis of drug activation. Cancer Res. 49, 2344-2350 (1989).
30. J. B. Schenkman: Induction of diabetes and evaluation of diabetic state on P450 expression. In "Methods in Enzymology, Volume 206: Cytochrome P450" (M. R. Waterman and E. F. Johnson, eds.), pp. 325-331. Academic Press, San Diego, 1991.
31. F. P. Guengerich, and T. Shimada: Oxidation of toxic and carcinogenetic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391-407 (1991).
32. M. Komori, K. Nishio, M. Kitada, K. Shiramatsu, K. Muroya, K. Soma, K. Nagashima, and T. Kamataki: Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry 29, 4430-4433 (1990).
33. F. Morel, P. H. Beaune, D. Ratanasavanh, J. P. Flinois, C. S. Yang, F. P. Guengerich, and A. Guillouzo: Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur. J. Biochem. 191, 437-444 (1990).
34. F. P. Guengerich: Mechanism-based inactivation of human liver cytochrome P-450 IIIA by gestodene. Chem. Res. Toxicol. 3, 363-371 (1990).
35. M. Delaforge, E. Sartori, and D. Mansuy: In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin. Chem. Biol. Interact. 68, 179-188 (1988).